Source: Molecular Simulations. Unidade: FCFRP
Subjects: NEOPLASIAS, QUÍMICA FARMACÊUTICA, PLANEJAMENTO DE FÁRMACOS, MODELAGEM MOLECULAR, HOMOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEMIGHINI, Evandro P. e TAFT, Carlton A. e SILVA, Carlos Henrique Tomich de Paula da. Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design. Molecular Simulations, v. 37, n. 14, p. 1186-1206, 2011Tradução . . Disponível em: https://doi.org/10.1080/08927022.2011.589052. Acesso em: 11 out. 2024.APA
Semighini, E. P., Taft, C. A., & Silva, C. H. T. de P. da. (2011). Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design. Molecular Simulations, 37( 14), 1186-1206. doi:10.1080/08927022.2011.589052NLM
Semighini EP, Taft CA, Silva CHT de P da. Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design [Internet]. Molecular Simulations. 2011 ; 37( 14): 1186-1206.[citado 2024 out. 11 ] Available from: https://doi.org/10.1080/08927022.2011.589052Vancouver
Semighini EP, Taft CA, Silva CHT de P da. Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design [Internet]. Molecular Simulations. 2011 ; 37( 14): 1186-1206.[citado 2024 out. 11 ] Available from: https://doi.org/10.1080/08927022.2011.589052
